Decadron and Cabometyx drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Decadron (dexamethasone) and Cabometyx (cabozantinib s-malate). Common drug interactions include fatigue among females and malignant neoplasm progression among males.

The phase IV clinical study analyzes what interactions people have when they take Decadron and Cabometyx. It is created by eHealthMe based on reports of 66 people who take the same drugs from the FDA, and is updated regularly.

What is Decadron?

Decadron has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 47,210 Decadron users. Check the latest studies of Decadron.

What is Cabometyx?

Cabometyx has active ingredients of cabozantinib s-malate. eHealthMe is studying from 35,069 Cabometyx users. Check the latest studies of Cabometyx.

On Jul, 12, 2026

66 people who take Decadron and Cabometyx together, and have interactions are studied.

Decadron and Cabometyx drug interactions.

What are the common drug interactions of Decadron and Cabometyx, by gender? *:

female:

Fatigue (feeling of tiredness)
Malignant neoplasm progression (cancer tumour came back)
Acute sinusitis
Anaemia (lack of blood)
Autoimmune hepatitis
Autoimmune myocarditis (inflammation of the heart muscle by immune system disorder)
Blood calcium increased
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Escherichia urinary tract infection (urinary tract infection by escherichia coli)
Fall

male:

Malignant neoplasm progression (cancer tumour came back)
Pneumonia
Skin ulcer
Ageusia (loss of taste functions of the tongue)
Dysphonia (speech disorder attributable to a disorder of phonation)
Acute respiratory failure
Ascites (accumulation of fluid in the abdominal cavity)
Cellulitis (infection under the skin)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Hyperthyroidism (over activity of the thyroid gland)

What are the common drug interactions of Decadron and Cabometyx, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Malignant neoplasm progression (cancer tumour came back)
Nausea (feeling of having an urge to vomit)
Pain in extremity
Peripheral swelling
Pleural effusion (water on the lungs)
Pneumonia klebsiella (pneumonia caused by bacteria klebsiella)
Renal failure (kidney dysfunction)
Septic shock (shock due to blood infection)
Vomiting

30-39:

Ascites (accumulation of fluid in the abdominal cavity)

40-49:

Ammonia increased
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Blood pressure increased
Decreased appetite
Erythema (redness of the skin)
Fall
Fatigue (feeling of tiredness)
Hepatic enzyme increased
Hypertension (high blood pressure)
Peripheral swelling

50-59:

Diarrhoea
Dysphonia (speech disorder attributable to a disorder of phonation)
Fatigue (feeling of tiredness)
Genital rash (rash on sex organ)
Haemorrhagic diathesis (bleeding tendency)
Hypercalcaemia of malignancy (elevated calcium (ca+) level in the blood with cancer)
Hypertension (high blood pressure)
Laceration (tearing of soft body tissue)
Lymphadenopathy (disease or enlargement of lymph nodes)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)

60+:

Back pain
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Gastrointestinal mucosal necrosis (damage of mucous membrane in gastrointestinal tract)
Portal venous gas (presence of gas in the bowel wall)
Decreased appetite
Nausea (feeling of having an urge to vomit)
Vomiting
Weight decreased
Malignant neoplasm progression (cancer tumour came back)
Oedema peripheral (superficial swelling)

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 36 people, 54.55%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 12 people, 18.18%
Metastases To Bone (cancer spreads to bone): 10 people, 15.15%
Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 7 people, 10.61%
Renal Cancer Metastatic (cancer of kidney spreads to other part): 4 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Decadron and Cabometyx?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously